(11aS)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 5-oxide

Request For Quotation
(11aS)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 5-oxide Suppliers list
Company Name: Daicel Chiral Technologies (China)CO.,LTD  
Tel: 021-50460086-9 15921403865
Email: han_yajun@dctc.daicel.com
Company Name: Tianjin Derchemist Science & Technology Co., Ltd.  
Tel: 22-58627059 13920586291
Email: zdcomcon@126.com
Company Name: Shanghai Chiral bio-compound co., Ltd.  
Tel: 021-5068 3667/17749785980/1029026415; 17749785980
Email: 1029026415@qq.com
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 15026964105
Email: 2881489226@qq.com
Company Name: Greenherbs Science and Technology Development Co., Ltd.  
Tel: 010-61136123
Email: pub02@greenherbs.com.cn
(11aS)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 5-oxide Basic information
Reaction
Product Name:(11aS)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 5-oxide
Synonyms:(11aS)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 5-oxide;(11aS)-5-oxide-3,7-bis[3,5-bis(trifluoroMethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-Diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin;(11aS)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12, 13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg] [1,3,2]dioxaphosphocin;(11aS)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin,99%e.e.;(11AS)-3,7-BIS[3,5-BIS(TRIFLUOROMETHYL)PHENYL]-10,11,12,13-TETRAHYDRO-5-HYDROXY-5-OXIDE-DIINDENO[7,1-DE:1',7'-FG][1,3,2]DIOXAPHOSPHOCIN,MIN.98%;(11aS)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, min. 98%;Diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 3,7-bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-, 5-oxide, (11aS)-;(11aS)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1'',7''-fg][1,3,2]dioxaphosphocin
CAS:1258327-07-9
MF:C33H19F12O4P
MW:738.46
EINECS:
Product Categories:
Mol File:1258327-07-9.mol
(11aS)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 5-oxide Structure
(11aS)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 5-oxide Chemical Properties
Melting point >300℃
Boiling point 642.3±65.0 °C(Predicted)
density 1.64±0.1 g/cm3 (20 ºC 760 Torr)
storage temp. 2-8°C, protect from light, stored under nitrogen
pka1.13±0.20(Predicted)
form Powder
color white to light-yellow
Safety Information
MSDS Information
(11aS)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 5-oxide Usage And Synthesis
Reaction
  1. Organocatalytic asymmetric multicomponent reactions of aromatic aldehydes and anilines with β-ketoesters: facile and atomeconomical access to chiral tetrahydropyridines.
  2. Pd(0)-catalyzed tandem deprotection/cyclization of tetrahydro-β-carbolines on allenes: application to the synthesis of indolo[2,3-α]quinolizidines.
  3. Enantioselective synthesis of benzazepinoindoles bearing trifluoromethylated quaternary stereocenters, catalyzed by chiral spirocyclic phosphoric acids.
Reactions of 1258327-07-9
(11aS)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 5-oxide Preparation Products And Raw materials
Tag:(11aS)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 5-oxide(1258327-07-9) Related Product Information
(11aS)- 5-oxide-3,7-di-9-anthracenyl-10,11,12,13-tetrahydro-5-hydroxy-Diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin (11aS)-3,7-Bis(triphenylsilyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin (11aS)-3,7-Bis(4-(trifluoromethyl)phenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin (11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis(4-nitrophenyl)-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-oxide (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-diphenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-oxide (11aR)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 5-oxide